How Ph.D. was paid
$2.5M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Alfred Sandrock, M.D., Ph.D.Chief Executive Officer, President, and Director | $674,903 | $611,900 | $843,900 | $361,917 | $15,750 | $2,508,370 |
| Jacquelyn Fahey SandellFormer Chief Legal Officer | $297,842 | $175,130 | $241,530 | — | $760,484 | $1,474,986 |
| Robin SwartzChief Business Officer & Chief Operating Officer | $520,190 | $300,675 | $414,675 | $205,475 | $13,285 | $1,454,300 |
| Toby Ferguson, M.D., Ph.D.Former Chief Medical Officer | $513,369 | $265,860 | $366,660 | $202,781 | $15,750 | $1,364,420 |
What changed and why
- $2.5MAlfred Sandrock earned $2,508,370 in total compensation for 2025, representing a decrease from the prior year.
- $612KStock awards for the CEO totaled $611,900 alongside option awards valued at $843,900.
- 94.9%The company maintained compensation practices based on robust stockholder support of 94.9% at the prior meeting.
- Performance-based variable cash bonuses were earned for the 2025 performance year and paid in February 2026.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.